Taking care of ourselves is more important than ever. Two major pieces to the self-care puzzle are sleep and nutrition. However, that may not be enough. Research is mounting to suggest that there are very real and important implications for when we eat....
M-Gard is yeast-derived beta glucans (Saccharomyces cerevisiae) that work as an immune-enhancing agent. The natural yeast beta 1,3/1,6 glucan was developed by using a proprietary process that extracts the ingredient from the cell wall of a proprietary...
Ireland’s Kerry Group has acquired the Quebec family biotechnology company Bio-K+ International Inc., allowing the Bio-K+ brand to expand globally through Kerry.
Partnerships and collaboration are going to drive the rapid advances needed in the microbiome space to better feed animals and humans, says the President of Cargill Health Technologies.
ProDigest and Biofortis are to enter into an agreement to strengthen and enlarge their service offerings that currently includes microbiome research and probiotic and botanical extract efficacy.
Biotech startup Kaffe Bueno has secured over one million in seed funding, enabling it to push ahead with a flurry of active cosmetic ingredient launches targeting inside-out beauty, anti-ageing and sun protection, its CEO says.
Lonza’s €78.2m ($93m) investment in its Capsules and Health Ingredients (CHI) Division will increase the capsule production capacity by 15%, according to company executives.
US ingredient giants ADM are to expand its microbiome-related production activities five-fold with the creation of a European facility that is expected to be in operation in 2022.
In a new personalised nutrition pact, Italian botanicals firm Indena are to use Onegevity’s capabilities in gut microbiome testing to identify botanical ingredients that best produce person-specific benefits.
Gencor’s Levagen, a clinically studied form of palmitolethanolamide (PEA), has been granted novel foods certification by Brazil’s National Health Surveillance Agency ANVISA.
Swiss L-carnitine supplier Lonza has said focus on a lone metabolite that has a poorly understood relation to cardiovascular disease presents an incomplete picture of the benefits of the ingredient. The warning about the metabolite figured into a recently...
As sales of dietary supplements and natural products remain high – and many companies report record sales – the strain on the supply chain is immense, and for botanicals in particular, and that means a difficult 2021 could be on the horizon.
